SCHEMBL9335141

SCHEMBL9335141

CCCCCCCN(CCCCCSc1nc2ccccc2n1C)C(=O)Nc1ccc(F)cc1F

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ ACAT1 P24752 1/20 0.60

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9375757 0.86 ACAT1 (0.69) ACAT1
SCHEMBL9335674 0.81 ACAT1 (0.61) ACAT1
SCHEMBL9332405 0.81 ACAT1 (0.61) ACAT1
SCHEMBL9332852 0.81 ACAT1 (0.73) ACAT1
SCHEMBL9425382 0.80 ACAT1 (0.67) ACAT1
SCHEMBL9332518 0.78 ACAT1 (0.69) ACAT1
SCHEMBL9375747 0.76 ACAT1 (0.73) ACAT1
Lecimibide SCHEMBL49619 0.75 ACAT1 (1.00) ACAT1
SCHEMBL9370595 0.75 ACAT1 (1.00) ACAT1
Lecimibide SCHEMBL30548840 0.75 ACAT1 (1.00) ACAT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5290801-A Anticholesterol or antilipemic agents THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1994-03-01 — — US claimed
US-5290801-A Anticholesterol or antilipemic agents THE DU PONT MERCK PHARMACEUTICAL COMPANY (US) 1994-03-01 — — US disclosed
Send feedback